Literature DB >> 18699758

Rational targeting of Notch signaling in breast cancer.

Lucio Miele.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18699758     DOI： 10.1586/14737140.8.8.1197

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  10 in total

1.  Identification of differential expressed transcripts in cervical cancer of Mexican patients.

Authors:  Leticia Santos; Ma Fabiola León-Galván; Erika Nahomy Marino-Marmolejo; Ana Paulina Barba de la Rosa; Antonio De León Rodríguez; Roberto González-Amaro; Ramón Gerardo Guevara-González
Journal:  Tumour Biol       Date:  2011-01-13

Review 2.  Cancer stem cells: potential target for bioactive food components.

Authors:  Young S Kim; William Farrar; Nancy H Colburn; John A Milner
Journal:  J Nutr Biochem       Date:  2012-07       Impact factor: 6.048

3.  Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer.

Authors:  Veronika Mamaeva; Jessica M Rosenholm; Laurel Tabe Bate-Eya; Lotta Bergman; Emilia Peuhu; Alain Duchanoy; Lina E Fortelius; Sebastian Landor; Diana M Toivola; Mika Lindén; Cecilia Sahlgren
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

4.  Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells.

Authors:  Brandi B Knight; Gabriela M Oprea-Ilies; Arumugam Nagalingam; Lily Yang; Cynthia Cohen; Neeraj K Saxena; Dipali Sharma
Journal:  Endocr Relat Cancer       Date:  2011-07-01       Impact factor: 5.678

5.  Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.

Authors:  L Hao; P Rizzo; C Osipo; A Pannuti; D Wyatt; L W-K Cheung; G Sonenshein; B A Osborne; L Miele
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

Review 6.  ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches.

Authors:  Jin-Qiang Chen; Jose Russo
Journal:  Biochim Biophys Acta       Date:  2009-06-13

7.  Associating GWAS Information with the Notch Signaling Pathway Using Transcription Profiling.

Authors:  Chindo Hicks; Antonio Pannuti; Lucio Miele
Journal:  Cancer Inform       Date:  2011-04-06

8.  NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.

Authors:  Anthony G Clementz; Allison Rogowski; Kinnari Pandya; Lucio Miele; Clodia Osipo
Journal:  Breast Cancer Res       Date:  2011-06-14       Impact factor: 6.466

9.  Notch3 inhibits epithelial-mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells.

Authors:  X Zhang; X Liu; J Luo; W Xiao; X Ye; M Chen; Y Li; G-J Zhang
Journal:  Oncogenesis       Date:  2016-11-14       Impact factor: 7.485

10.  'Normalizing' the malignant phenotype of luminal breast cancer cells via alpha(v)beta(3)-integrin.

Authors:  Hanan Abu-Tayeh; Keren Weidenfeld; Alisa Zhilin-Roth; Sagi Schif-Zuck; Sonja Thaler; Cristina Cotarelo; Tuan Z Tan; Jean P Thiery; Jeffrey E Green; Geula Klorin; Edmond Sabo; Jonathan P Sleeman; Maty Tzukerman; Dalit Barkan
Journal:  Cell Death Dis       Date:  2016-12-01       Impact factor: 8.469
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.